Single vaccine dose shows 84% effectiveness against mpox, but insufficient for HIV patients
Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...
Devdiscourse4h
Trump Administration Axes Vaccine Aid Amid 'America First' Policy
The Trump administration plans to cease U.S. funding for Gavi, a vital organization aiding vaccine procurement for children ...
Foreign aid cuts will lead to more HIV infections and deaths, study suggests
HIV infections and deaths will rise as a result of cuts to foreign aid, according to a study. Researchers said that funding ...
Science Daily6d
New data on Mpox vaccine effectiveness
A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...
Memphis company lands Department of Defense contract for vaccine delivery
Department of Defense initiative's first-use case would be for HIV vaccine delivery via a platform developed by a ...
Healio7d
Increasing HPV vaccine coverage may decrease cancers among people with HIV
Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from ...
Q&A: Nobel Prize-winning researcher and BU grad discusses vaccine development, vaccine hesitancy, and preparing for another pandemic
Weissman was jointly awarded the 2023 Nobel Prize in Medicine with Katalin Karikó for discoveries which made COVID-19 ...
U.S. to end vaccine funds for poor countries
A 281-page spreadsheet obtained by The New York Times lists the Trump administration’s plans for thousands of foreign aid ...
EurekAlert!8d
Charité study yields new data on Mpox vaccine effectiveness
Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% ...
CIDRAP7d
Estimates: Jynneos mpox vaccine 84% and 35% effective in people without, with HIV
One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...
News2415d
US funding cuts imperil search for HIV vaccine
A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by abrupt US funding cuts. As a result, several promising vaccine candidates might not be tested ...